Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

Kai Wen Huang, Shieh Yueh Yang, Yu Wei Hong, Jen Jie Chieh, Che Chuan Yang, Herng Er Horng, Chau Chung Wu, Chin Yih Hong, Hong Chang Yang

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.

Original languageEnglish
Pages (from-to)1991-1996
Number of pages6
JournalInternational Journal of Nanomedicine
Volume7
DOIs
Publication statusPublished - 2012 Dec 5

Fingerprint

alpha-Fetoproteins
Feasibility Studies
Antibodies
Nanoparticles
Assays
Immunosorbents
Enzymes
Enzyme-Linked Immunosorbent Assay
Biomolecules
Bearings (structural)
Hemoglobin
Serum
Bilirubin
Liver
Vascular Endothelial Growth Factor A
Labels
Tumors
Hemoglobins
Triglycerides
Blood

Keywords

  • Biofunctionalized magnetic nanoparticles
  • ELISA
  • Immunomagnetic reduction

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry

Cite this

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles. / Huang, Kai Wen; Yang, Shieh Yueh; Hong, Yu Wei; Chieh, Jen Jie; Yang, Che Chuan; Horng, Herng Er; Wu, Chau Chung; Hong, Chin Yih; Yang, Hong Chang.

In: International Journal of Nanomedicine, Vol. 7, 05.12.2012, p. 1991-1996.

Research output: Contribution to journalArticle

Huang, Kai Wen ; Yang, Shieh Yueh ; Hong, Yu Wei ; Chieh, Jen Jie ; Yang, Che Chuan ; Horng, Herng Er ; Wu, Chau Chung ; Hong, Chin Yih ; Yang, Hong Chang. / Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles. In: International Journal of Nanomedicine. 2012 ; Vol. 7. pp. 1991-1996.
@article{e538877de5df46a8a040b2997c0a2114,
title = "Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles",
abstract = "Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.",
keywords = "Biofunctionalized magnetic nanoparticles, ELISA, Immunomagnetic reduction",
author = "Huang, {Kai Wen} and Yang, {Shieh Yueh} and Hong, {Yu Wei} and Chieh, {Jen Jie} and Yang, {Che Chuan} and Horng, {Herng Er} and Wu, {Chau Chung} and Hong, {Chin Yih} and Yang, {Hong Chang}",
year = "2012",
month = "12",
day = "5",
doi = "10.2147/IJN.S28245",
language = "English",
volume = "7",
pages = "1991--1996",
journal = "International Journal of Nanomedicine",
issn = "1176-9114",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles

AU - Huang, Kai Wen

AU - Yang, Shieh Yueh

AU - Hong, Yu Wei

AU - Chieh, Jen Jie

AU - Yang, Che Chuan

AU - Horng, Herng Er

AU - Wu, Chau Chung

AU - Hong, Chin Yih

AU - Yang, Hong Chang

PY - 2012/12/5

Y1 - 2012/12/5

N2 - Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.

AB - Some previous reports have already shown the characterizations of immunomagnetic reduction (IMR). The assay technology involves the utilities of biofunctionalized magnetic nanoparticles to label target biomolecules. However, the detection threshold and interference tests for IMR have not been investigated in detail. In this study, alpha-fetoprotein (AFP) was used as a target biomolecule. The signals for AFP solutions of various concentrations, or with interfering materials, were detected via IMR. These samples were also used for characterizing the detection threshold and interference with enzyme-linked immunosorbent assay (ELISA). The results of assaying AFP level with IMR and ELISA were compared. The detection threshold for assaying AFP with IMR was found to be 3 ng/mL, which is 15 times lower than that of ELISA, and definitely suppresses false negative. For the interfering materials noted commonly in serum such as hemoglobin, bilirubin, triglyceride, and vascular endothelial growth factor, there was no detectable interfering effect when assaying AFP with IMR. Several serum samples from normal people and liver-tumor-bearing patients were used for the detections of AFP concentration via IMR. These results reveal the feasibilities of assaying AFP in blood using IMR, as well as achieving high-sensitive and high-specific assay for AFP.

KW - Biofunctionalized magnetic nanoparticles

KW - ELISA

KW - Immunomagnetic reduction

UR - http://www.scopus.com/inward/record.url?scp=84866747613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866747613&partnerID=8YFLogxK

U2 - 10.2147/IJN.S28245

DO - 10.2147/IJN.S28245

M3 - Article

C2 - 22619536

AN - SCOPUS:84866747613

VL - 7

SP - 1991

EP - 1996

JO - International Journal of Nanomedicine

JF - International Journal of Nanomedicine

SN - 1176-9114

ER -